Second, many clinical studies have evaluated factors that are related to HCC prognosis based on 3-year survival, whereas we demonstrated that HBV factors and AKT1 exert an additive effect on the 5-year survival of patients with HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.